دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Reducing the uses of valproate: a controversial decision
doi : 10.1016/S1474-4422(23)00507-0
Volume 23, Issue 2, February 2024, Page 123
The difficulties in treating children with rare epileptic encephalopathies
Shefali Karkare, *Sanjeev V Kothare
doi : 10.1016/S1474-4422(23)00448-9
Volume 23, Issue 2, February 2024, Pages 124-125
Platelet glycoprotein VI inhibition: a promising therapeutic avenue in acute ischaemic stroke
Aravind Ganesh
doi : 10.1016/S1474-4422(23)00460-X
Volume 23, Issue 2, February 2024, Pages 125-127
Posterior cortical atrophy: new insights into treatments and biomarkers for Alzheimer's disease
Alexandre Bejanin, Nicolas Villain
doi : 10.1016/S1474-4422(23)00501-X
Volume 23, Issue 2, February 2024, Pages 127-128
Criteria for a biological definition of neuronal α-synuclein disease—a major conceptual step forward
Clifford R Jack Jr
doi : 10.1016/S1474-4422(23)00456-8
Volume 23, Issue 2, February 2024, Pages 129-130
Has the time come to redefine Parkinson's disease?
Sirwan K L Darweesh, Cristina Sampaio, *Bastiaan R Bloem
doi : 10.1016/S1474-4422(23)00503-3
Volume 23, Issue 2, February 2024, Pages 130-133
Parkinson's disease is a recognisable and useful diagnostic entity
*Jose A Obeso, Paolo Calabressi
doi : 10.1016/S1474-4422(23)00512-4
Volume 23, Issue 2, February 2024, Pages 133-134
Deciphering spinal muscular atrophy: the need for more research
*Michelle Anne Farrar, Didu Sanduni Kariyawasam
doi : 10.1016/S1474-4422(23)00502-1
Volume 23, Issue 2, February 2024, Pages 134-136
Venglustat in GBA1-related Parkinson's disease
Ari Zimran, Shoshana Revel-Vilk, Michal Becker-Cohen, *Majdolen Istaiti, Arndt Rolfs
doi : 10.1016/S1474-4422(23)00455-6
Volume 23, Issue 2, February 2024, Page 137
Venglustat in GBA1-related Parkinson's disease – Authors' reply
S Pablo Sardi
doi : 10.1016/S1474-4422(23)00470-2
Volume 23, Issue 2, February 2024, Pages 137-138
A multipronged approach to advancing palliative care for people with intellectual disabilities
*Kwok Ying Chan, Kwok Wai Tsang
doi : 10.1016/S1474-4422(23)00452-0
Volume 23, Issue 2, February 2024, Page 138
A multipronged approach to advancing palliative care for people with intellectual disabilities – Author's reply
Benzi M Kluger
doi : 10.1016/S1474-4422(23)00499-4
Volume 23, Issue 2, February 2024, Pages 138-139
Rapid genome sequencing for infantile-onset epilepsy within a national health-care setting
Hannah K Robinson, Karen Stals, Sue Hill, Andrew Parrish, *Emma L Baple
doi : 10.1016/S1474-4422(23)00429-5
Volume 23, Issue 2, February 2024, Pages 139-140
WHO considers multiple sclerosis treatments essential
Joanna Laurson-Doube, Anne Helme, Francesco Nonino, Thomas Piggott, Nick Rijke, Deanna Saylor
doi : 10.1016/S1474-4422(23)00505-7
Volume 23, Issue 2, February 2024, Page 140
The AfrAbia+plus Parkinson's Disease Genomic Consortium
Wael Mohamed, Mohamed Abdelhalim Eltantawi, Yasser Mecheri, Yared Zenebe Zewde, Walaa A Kamel, Bashayer R Al-Mubarak, Karem H Alzoubi, Najib Kissani, Badrah S Alghamdi, Samia Ben Sassi, on behalf of the AfrAbia+plus Parkinson’s Disease Genomic Consortium
doi : 10.1016/S1474-4422(23)00453-2
Volume 23, Issue 2, February 2024, Pages 140-141
Correction to Lancet Neurol 2023; 22: 1089–91
doi : 10.1016/S1474-4422(23)00511-2
Volume 23, Issue 2, February 2024, Page e2
Rhonda Voskuhl: basketball and bedside to bench to bedside
doi : 10.1016/S1474-4422(24)00002-4
Volume 23, Issue 2, February 2024, Page 142
Crystal Jing Jing Yeo
doi : 10.1016/S1474-4422(23)00500-8
Volume 23, Issue 2, February 2024, Page 143
A chance to prevent Alzheimer's disease sooner than you think
Eric M Reiman, Jeffrey L Cummings, Jessica B Langbaum, Soeren Mattke, Robert C Alexander
doi : 10.1016/S1474-4422(23)00508-2
Volume 23, Issue 2, February 2024, Pages 144-145
I am what I am
Marco De Ambrogi
doi : 10.1016/S1474-4422(23)00509-4
Volume 23, Issue 2, February 2024, Page 146
Corticosteroids versus clobazam for treatment of children with epileptic encephalopathy with spike-wave activation in sleep (RESCUE ESES): a multicentre randomised controlled trial
Marleen M L van Arnhem*, Bart van den Munckhof*, Alexis Arzimanoglou, Emilio Perucca, Liisa Mets?honkala, Guido Rubboli, Marianne S?ndergaard Khinchi, Anne de Saint-Martin, Kerstin A Klotz, Julia Jacobs, J Helen Cross, Irene Garcia Morales, Wim M Otte, Heleen C van Teeseling, Frans S S Leijten, Kees P J Braun, Floor E Jansen, on behalf of the RESCUE ESES study groupâ€
doi : 10.1016/S1474-4422(23)00409-X
Volume 23, Issue 2, February 2024, Pages 147-156
Safety and efficacy of platelet glycoprotein VI inhibition in acute ischaemic stroke (ACTIMIS): a randomised, double-blind, placebo-controlled, phase 1b/2a trial
Mikaël Mazighi, Martin Ko?hrmann, Robin Lemmens, Philippe A Lyrer, Carlos A Molina, S ébastien Richard, Danilo Toni, Yannick Plétan, Anouar Sari, Adeline Meilhoc, Martine Jandrot-Perrus, Sophie Binay, Gilles Avenard, Andrea Comenducci, Jean-Marie Grouin, James C Grotta, on behalf of the ACTIMIS Study Group
doi : 10.1016/S1474-4422(23)00427-1
Volume 23, Issue 2, February 2024, Pages 157-167
Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis
Marianne Chapleau*, Renaud La Joie*, Keir Yong, Federica Agosta, Isabel Elaine Allen, Liana Apostolova, John Best, Baayla D C Boon, Sebastian Crutch, Massimo Filippi, Giorgio Giulio Fumagalli, Daniela Galimberti, Jonathan Graff-Radford, Lea T Grinberg, David J Irwin, Keith A Josephs, Mario F Mendez, Patricio Chrem Mendez, Raffaella Migliaccio, Zachary A Miller, Maxime Montembeault, Melissa E Murray, S?ra Nemes, Victoria Pelak, Daniela Perani, Jeffrey Phillips, Yolande Pijnenburg, Emily Rogalski, Jonathan M Schott, William Seeley, A Campbell Sullivan, Salvatore Spina, Jeremy Tanner, Jamie Walker, Jennifer L Whitwell, David A Wolk, Rik Ossenkoppele, Gil D Rabinovici, on behalf of the PCA International Work Groupâ€
doi : 10.1016/S1474-4422(23)00414-3
Volume 23, Issue 2, February 2024, Pages 168-177
A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research
Tanya Simuni*, Lana M Chahine*, Kathleen Poston, Michael Brumm, Teresa Buracchio, Michelle Campbell, Sohini Chowdhury, Christopher Coffey, Luis Concha-Marambio, Tien Dam, Peter DiBiaso, Tatiana Foroud, Mark Frasier, Caroline Gochanour, Danna Jennings, Karl Kieburtz, Catherine M Kopil, Kalpana Merchant, Brit Mollenhauer, Thomas Montine, Kelly Nudelman, Gennaro Pagano, John Seibyl, Todd Sherer, Andrew Singleton, Diane Stephenson, Matthew Stern, Claudio Soto, Caroline M Tanner, Eduardo Tolosa, Daniel Weintraub, Yuge Xiao, Andrew Siderowf, Billy Dunn, Kenneth Marek
doi : 10.1016/S1474-4422(23)00405-2
Volume 23, Issue 2, February 2024, Pages 178-190
A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria
Günter U H?glinger, Charles H Adler, Daniela Berg, Christine Klein, Tiago F Outeiro, Werner Poewe, Ronald Postuma, A Jon Stoessl, Anthony E Lang
doi : 10.1016/S1474-4422(23)00404-0
Volume 23, Issue 2, February 2024, Pages 191-204
Challenges and opportunities in spinal muscular atrophy therapeutics
Crystal J J Yeo, Eduardo F Tizzano, Basil T Darras
doi : 10.1016/S1474-4422(23)00419-2
Volume 23, Issue 2, February 2024, Pages 205-218
